艾滋病毒Vpr激活了一个核细胞特异的ATR通路,以降低核细胞应激传感器CCDC1377
Karly A Nisson1, Rishi S Patel2, Yennifer Delgado1
1Molecular Biology Institute, University of California, Los Angeles, CA, 90095, United States.
Nucleic acids research
|June 18, 2025
概括
病毒蛋白Vpr通过降解CCDC137,一种感知核干扰的蛋白质,引起核应激. 这种Vpr诱导的核细胞应激会影响核糖体生物发生和细胞通路.
科学领域:
- 病毒学 病毒学
- 分子生物学分子生物学
- 细胞生物学 细胞生物学
背景情况:
- 病毒蛋白Vpr与细胞通路相互作用,导致宿主产生诸如DNA损伤反应 (DDR) 和G2/M停止等后果.
- 通过Vpr影响这些通路并影响其他细胞过程的精确机制仍然不完全理解.
研究的目的:
- 通过检查Vpr介导的核蛋白CCDC137.7的耗尽,研究Vpr诱导的DDR激活如何影响核细胞过程.
- 描述CCDC137降解在Vpr更广泛的细胞效应中的作用.
主要方法:
- 描述CCDC137作为一个间接的Vpr目标.
- 在对Vpr和基因组侮辱的反应中分析CCDC137降解.
- 核细胞应激标记的评估,包括蛋白质再分配,形态变化和核糖体生物发生,在Vpr.
- 研究ATR通路在Vpr诱导的核应激中的参与.
主要成果:
- CCDC137是一种间接的Vpr标,其降解与Vpr诱导的G2/M停止没有相关性.
- CCDC137的降解在不同的lentiviral Vpr蛋白中保存,并由基因组侮辱激活核细胞ATR通路而触发.
- Vpr诱导ATR依赖的核细胞应激,其特征是核细胞蛋白重新分配,改变形态和抑制的核糖体生物发生,这与CCDC137降解相关.
结论:
- CCDC137作为非正规的Vpr目标,并可能作为核细胞中断的传感器.
- 在诱导核应激方面,Vpr起着新的作用,通过CCDC137降解和ATR通路激活,影响核糖体生物发生和细胞功能.
更多相关视频
10:12Author Spotlight: Exploring the Role of Unfolded Protein Response in HIV-1 Replication and Infectivity
Published on: June 14, 2024
2.1K
08:33Nucleocapsid Annealing-Mediated Electrophoresis NAME Assay Allows the Rapid Identification of HIV-1 Nucleocapsid Inhibitors
Published on: January 19, 2015
9.0K
相关概念视频
Anaphase Promoting Complex
3.0K
The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
3.0K
DNA Damage can Stall the Cell Cycle
9.3K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.3K
The Unfolded Protein Response
5.1K
The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
5.1K
Regulation of Nuclear Protein Sorting
2.4K
Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
2.4K
cAMP-dependent Protein Kinase Pathways
6.7K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
6.7K
Regulation of the Unfolded Protein Response
2.6K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.6K
